HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin

Justine Varinot, Olivier Cussenot, Morgan Roupret, Pierre Conort, Marc Olivier Bitker, Emmanuel Chartier-Kastler, Liang Cheng, Eva Compérat

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The origin of a primary or metastatic carcinoma in the pelvic area is sometimes difficult to establish, in particular the distinction between those originating in the bladder and the prostate. A candidate marker is the HOXB13 gene, essential for prostate development. Some studies have shown expression of HOXB13 protein by immunohistochemistry in the nuclear compartment of benign prostate luminal epithelium and prostate carcinoma. Forty-two cases of biopsies and resection specimens of the prostate and urinary bladder, metastatic lymph nodes, and pelvic masses were retrieved from our databases. In all cases, doubt persisted regarding prostatic versus urothelial origin. All cases were stained for CK7, p63, p504s, PSA, CK20, and HOXB13. Chromogranin A, CD56, and synaptophysin were used when neuroendocrine differentiation was suspected. HOXB13 staining was negative or only weakly positive in all carcinomas of urothelial origin. Three of four carcinomas with neuroendocrine differentiation did not express HOXB13. The fourth carcinoma, in a patient with a history of prostate carcinoma, was positive. In two cases with a synchronous prostatic and urothelial carcinoma, HOXB13 was exclusively expressed in the prostatic carcinoma. Our results demonstrate that HOXB13 expression identifies prostatic origin of a carcinoma with good sensitivity (89 %) and very good specificity (100 %). HOXB13 is a specific and sensitive marker for prostate cells and a valuable diagnostic tool, especially when poorly differentiated or neuroendocrine tumors are encountered. These results justify testing of HOXB13 as a prostate-specific carcinoma marker in larger cohorts for a more thorough evaluation of its sensitivity and specificity.

Original languageEnglish
Pages (from-to)803-809
Number of pages7
JournalVirchows Archiv
Volume463
Issue number6
DOIs
StatePublished - Dec 2013

Fingerprint

Prostate
Carcinoma
Urinary Bladder
Neuroendocrine Carcinoma
Chromogranin A
Negative Staining
Synaptophysin
Neuroendocrine Tumors
Essential Genes
Epithelium
Lymph Nodes
Immunohistochemistry
Databases
Biopsy
Sensitivity and Specificity
Proteins

Keywords

  • Homeobox
  • HOXB13
  • Immunohistochemistry
  • Prostate carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Cite this

Varinot, J., Cussenot, O., Roupret, M., Conort, P., Bitker, M. O., Chartier-Kastler, E., ... Compérat, E. (2013). HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin. Virchows Archiv, 463(6), 803-809. https://doi.org/10.1007/s00428-013-1495-0

HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin. / Varinot, Justine; Cussenot, Olivier; Roupret, Morgan; Conort, Pierre; Bitker, Marc Olivier; Chartier-Kastler, Emmanuel; Cheng, Liang; Compérat, Eva.

In: Virchows Archiv, Vol. 463, No. 6, 12.2013, p. 803-809.

Research output: Contribution to journalArticle

Varinot, J, Cussenot, O, Roupret, M, Conort, P, Bitker, MO, Chartier-Kastler, E, Cheng, L & Compérat, E 2013, 'HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin', Virchows Archiv, vol. 463, no. 6, pp. 803-809. https://doi.org/10.1007/s00428-013-1495-0
Varinot, Justine ; Cussenot, Olivier ; Roupret, Morgan ; Conort, Pierre ; Bitker, Marc Olivier ; Chartier-Kastler, Emmanuel ; Cheng, Liang ; Compérat, Eva. / HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin. In: Virchows Archiv. 2013 ; Vol. 463, No. 6. pp. 803-809.
@article{b2efb408855f40bb8c8d98b77207d3c8,
title = "HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin",
abstract = "The origin of a primary or metastatic carcinoma in the pelvic area is sometimes difficult to establish, in particular the distinction between those originating in the bladder and the prostate. A candidate marker is the HOXB13 gene, essential for prostate development. Some studies have shown expression of HOXB13 protein by immunohistochemistry in the nuclear compartment of benign prostate luminal epithelium and prostate carcinoma. Forty-two cases of biopsies and resection specimens of the prostate and urinary bladder, metastatic lymph nodes, and pelvic masses were retrieved from our databases. In all cases, doubt persisted regarding prostatic versus urothelial origin. All cases were stained for CK7, p63, p504s, PSA, CK20, and HOXB13. Chromogranin A, CD56, and synaptophysin were used when neuroendocrine differentiation was suspected. HOXB13 staining was negative or only weakly positive in all carcinomas of urothelial origin. Three of four carcinomas with neuroendocrine differentiation did not express HOXB13. The fourth carcinoma, in a patient with a history of prostate carcinoma, was positive. In two cases with a synchronous prostatic and urothelial carcinoma, HOXB13 was exclusively expressed in the prostatic carcinoma. Our results demonstrate that HOXB13 expression identifies prostatic origin of a carcinoma with good sensitivity (89 {\%}) and very good specificity (100 {\%}). HOXB13 is a specific and sensitive marker for prostate cells and a valuable diagnostic tool, especially when poorly differentiated or neuroendocrine tumors are encountered. These results justify testing of HOXB13 as a prostate-specific carcinoma marker in larger cohorts for a more thorough evaluation of its sensitivity and specificity.",
keywords = "Homeobox, HOXB13, Immunohistochemistry, Prostate carcinoma",
author = "Justine Varinot and Olivier Cussenot and Morgan Roupret and Pierre Conort and Bitker, {Marc Olivier} and Emmanuel Chartier-Kastler and Liang Cheng and Eva Comp{\'e}rat",
year = "2013",
month = "12",
doi = "10.1007/s00428-013-1495-0",
language = "English",
volume = "463",
pages = "803--809",
journal = "Virchows Archiv",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin

AU - Varinot, Justine

AU - Cussenot, Olivier

AU - Roupret, Morgan

AU - Conort, Pierre

AU - Bitker, Marc Olivier

AU - Chartier-Kastler, Emmanuel

AU - Cheng, Liang

AU - Compérat, Eva

PY - 2013/12

Y1 - 2013/12

N2 - The origin of a primary or metastatic carcinoma in the pelvic area is sometimes difficult to establish, in particular the distinction between those originating in the bladder and the prostate. A candidate marker is the HOXB13 gene, essential for prostate development. Some studies have shown expression of HOXB13 protein by immunohistochemistry in the nuclear compartment of benign prostate luminal epithelium and prostate carcinoma. Forty-two cases of biopsies and resection specimens of the prostate and urinary bladder, metastatic lymph nodes, and pelvic masses were retrieved from our databases. In all cases, doubt persisted regarding prostatic versus urothelial origin. All cases were stained for CK7, p63, p504s, PSA, CK20, and HOXB13. Chromogranin A, CD56, and synaptophysin were used when neuroendocrine differentiation was suspected. HOXB13 staining was negative or only weakly positive in all carcinomas of urothelial origin. Three of four carcinomas with neuroendocrine differentiation did not express HOXB13. The fourth carcinoma, in a patient with a history of prostate carcinoma, was positive. In two cases with a synchronous prostatic and urothelial carcinoma, HOXB13 was exclusively expressed in the prostatic carcinoma. Our results demonstrate that HOXB13 expression identifies prostatic origin of a carcinoma with good sensitivity (89 %) and very good specificity (100 %). HOXB13 is a specific and sensitive marker for prostate cells and a valuable diagnostic tool, especially when poorly differentiated or neuroendocrine tumors are encountered. These results justify testing of HOXB13 as a prostate-specific carcinoma marker in larger cohorts for a more thorough evaluation of its sensitivity and specificity.

AB - The origin of a primary or metastatic carcinoma in the pelvic area is sometimes difficult to establish, in particular the distinction between those originating in the bladder and the prostate. A candidate marker is the HOXB13 gene, essential for prostate development. Some studies have shown expression of HOXB13 protein by immunohistochemistry in the nuclear compartment of benign prostate luminal epithelium and prostate carcinoma. Forty-two cases of biopsies and resection specimens of the prostate and urinary bladder, metastatic lymph nodes, and pelvic masses were retrieved from our databases. In all cases, doubt persisted regarding prostatic versus urothelial origin. All cases were stained for CK7, p63, p504s, PSA, CK20, and HOXB13. Chromogranin A, CD56, and synaptophysin were used when neuroendocrine differentiation was suspected. HOXB13 staining was negative or only weakly positive in all carcinomas of urothelial origin. Three of four carcinomas with neuroendocrine differentiation did not express HOXB13. The fourth carcinoma, in a patient with a history of prostate carcinoma, was positive. In two cases with a synchronous prostatic and urothelial carcinoma, HOXB13 was exclusively expressed in the prostatic carcinoma. Our results demonstrate that HOXB13 expression identifies prostatic origin of a carcinoma with good sensitivity (89 %) and very good specificity (100 %). HOXB13 is a specific and sensitive marker for prostate cells and a valuable diagnostic tool, especially when poorly differentiated or neuroendocrine tumors are encountered. These results justify testing of HOXB13 as a prostate-specific carcinoma marker in larger cohorts for a more thorough evaluation of its sensitivity and specificity.

KW - Homeobox

KW - HOXB13

KW - Immunohistochemistry

KW - Prostate carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84890552578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890552578&partnerID=8YFLogxK

U2 - 10.1007/s00428-013-1495-0

DO - 10.1007/s00428-013-1495-0

M3 - Article

C2 - 24146108

AN - SCOPUS:84890552578

VL - 463

SP - 803

EP - 809

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

IS - 6

ER -